NeuroSearch A/S (NEUR) was founded in 1989 and is listed on the stock exchange in Copenhagen (NASDAQ Copenhagen A/S).
In the period until 2012, the Company was involved in research and development activities with a view to bringing pharmaceuticals to market, primarily in the CNS segment. In 2012, following a number of failed initiatives and projects, the Company realised that it saw no longer feasible to obtain funding to continue operations. As a result, the Board of Directors resolved a plan to wind up the Company. This plan has now been successfully completed as the Company has wound up all activities and all assets except for cash of about DKK 70 million, the value of a tax loss and of its stock exchange listing.
In August 2018, Nordic Transport Group Holding (NTG Holding) became a major shareholder after obtaining an ownership interest of 22.54% in the Company following a takeover offer. NTG Holding has announced plans to merge the Company with Nordic Transport Group A/S, which requires the approval of the Company's shareholders at a general meeting.
For more details about the Company, please see Annual Report 2017 and subsequent company announcements.